| Recruiting | Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT) NCT07441720 | Zhejiang Cancer Hospital | Phase 2 |
| Recruiting | Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT NCT07442513 | First Affiliated Hospital of Zhejiang University | Phase 3 |
| Recruiting | Herombopag Treated T-DM1 Induced Platelet Reduction NCT07257809 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Not Yet Recruiting | A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 i NCT07185893 | Jun wang | N/A |
| Recruiting | Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT) NCT07110090 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 1 |
| Suspended | 177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cyt NCT07025512 | M.D. Anderson Cancer Center | Phase 2 |
| Not Yet Recruiting | Hematological Disorders in EHPVO Patients NCT07108023 | Rahab Nady | — |
| Recruiting | Neonatal Platelet Transfusion Threshold Trial NCT06676904 | NICHD Neonatal Research Network | N/A |
| Recruiting | Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury NCT06349577 | University of Colorado, Denver | N/A |
| Not Yet Recruiting | The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP NCT06913374 | Shandong University | Phase 2 / Phase 3 |
| Recruiting | Luspatercept for Clonal Cytopenias of Uncertain Significance NCT06788691 | Weill Medical College of Cornell University | Phase 2 |
| Recruiting | Apixaban in Thrombocytopenia NCT06886516 | Rushad Patell | EARLY_Phase 1 |
| Recruiting | UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia NCT06245746 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 1 |
| Completed | Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia NCT06824727 | Case Comprehensive Cancer Center | — |
| Recruiting | Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients NCT06673498 | Anhui Provincial Hospital | Phase 2 |
| Not Yet Recruiting | Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of Epilep NCT06491303 | Assiut University | — |
| Active Not Recruiting | Predicting Platelet Count From Viscoelastic Testing NCT06870851 | Kepler University Hospital | — |
| Recruiting | Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia NCT06562738 | The Third People's Hospital of Chengdu | Phase 4 |
| Recruiting | Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT NCT06202625 | Peking University People's Hospital | Phase 2 / Phase 3 |
| Withdrawn | The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune NCT06291415 | Hutchmed | Phase 1 |
| Recruiting | Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger NCT06187831 | Thomas Kander | — |
| Recruiting | Platelet-Directed Whole Blood Transfusion Strategy for Malaria NCT05711485 | Johns Hopkins Bloomberg School of Public Health | N/A |
| Completed | A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patient NCT06521931 | Chongqing Peg-Bio Biopharm Co., Ltd. | Phase 1 |
| Recruiting | Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia NCT05998759 | Beijing Hospital | Phase 2 |
| Not Yet Recruiting | Study Comparing Platelet Transfusion Volumes in Premature Babies NCT06095648 | University College Dublin | N/A |
| Completed | Clinical Performance Evaluation of T-TAS®01 HD Chip NCT06087198 | Hikari Dx, Inc. | — |
| Unknown | The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Main NCT06036966 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Unknown | Antiplatelet Therapy for AIS Patients With Thrombocytopenia NCT06053021 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Unknown | Assessment of Risk Factors and Outcome of Thrombocytopenia in ICU Patients NCT05958511 | Assiut University | — |
| Unknown | Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC NCT06001567 | Second Affiliated Hospital of Guangzhou Medical University | Phase 2 |
| Recruiting | Anti-CD38 Antibody Treating APS With Thrombocytopenia NCT05983952 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Completed | Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Pa NCT05944458 | Helwan University | Phase 4 |
| Completed | The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients NCT05944809 | JIANYANG WANG | Phase 2 |
| Completed | Comparative Study of Thrombocytopenia in Plasmodium Vivax and Falciparum Malaria NCT07122232 | Rafiullah Hotak | — |
| Completed | Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State NCT06768619 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | N/A |
| Completed | Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence NCT05634005 | University of Utah | N/A |
| Unknown | Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignanci NCT05672420 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 1 / Phase 2 |
| Unknown | A Multicenter Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITP NCT05411874 | Shandong University | Phase 2 |
| Recruiting | STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis NCT05255003 | Tzu-Fei Wang | Phase 4 |
| Unknown | Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITP NCT05410249 | Sohag University | — |
| Recruiting | Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy NCT06433830 | Sir Run Run Shaw Hospital | Phase 2 |
| Withdrawn | Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G) NCT04931849 | University of Rochester | EARLY_Phase 1 |
| Unknown | Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment NCT05382013 | Third Affiliated Hospital, Sun Yat-Sen University | Phase 4 |
| Unknown | National Vaccine Adverse Event Reporting Survey and Etiology NCT05095844 | Neuroganics LLC | — |
| Unknown | Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients NCT05217719 | Nanfang Hospital, Southern Medical University | Phase 4 |
| Recruiting | Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytope NCT05199909 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Unknown | A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Diseas NCT05193201 | Shenyang Sunshine Pharmaceutical Co., LTD. | Phase 1 |
| Active Not Recruiting | Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective S NCT05396157 | Mount Sinai Hospital, Canada | — |
| Completed | Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study NCT05053100 | Mayo Clinic | — |
| Unknown | Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Ca NCT05087459 | Shanghai Zhongshan Hospital | — |
| Unknown | Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia NCT04896528 | Peking Union Medical College Hospital | Phase 2 |
| Unknown | The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopen NCT05353673 | Peking University People's Hospital | Phase 2 |
| Completed | A Clinical Trial of Chidamide in the Management of Refractory ITP NCT03838354 | Shandong University | Phase 1 / Phase 2 |
| Recruiting | Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune C NCT04800458 | University Hospital, Bordeaux | N/A |
| Terminated | Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis NCT04543279 | Washington University School of Medicine | Phase 2 |
| Unknown | Collection of the Thrombo-VaxCov Cohort NCT04889326 | University Hospital, Lille | — |
| Unknown | Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patien NCT04797182 | Sun Yat-sen University | Phase 2 |
| Terminated | Thrombosomes® in Bleeding Thrombocytopenic Patients Study NCT04631211 | Cellphire Therapeutics, Inc. | Phase 2 |
| Unknown | Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia NCT04906083 | Tongji Hospital | Phase 4 |
| Unknown | Effect of Herbal Formulation on Thrombocytes Count NCT05563064 | Shifa Ul Mulk Memorial Hospital | Phase 3 |
| Unknown | Platelet Augmentation Using C. Papaya Leaf Extract in Live Donor Liver Transplantation NCT05360134 | Institute of Liver and Biliary Sciences, India | N/A |
| Completed | Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma NCT04673266 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker NCT04003220 | University Hospital, Bordeaux | — |
| Completed | Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP NCT04917679 | Qilu Hospital of Shandong University | Phase 2 |
| Completed | TPO-Mimetic Use in Children for Hematopoietic Failure NCT04478227 | Anjali Sharathkumar | EARLY_Phase 1 |
| Withdrawn | Platelet Transfusion in Sepsis Trial NCT03968484 | University Hospital Tuebingen | N/A |
| Completed | Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) NCT04272970 | Institut National de la Santé Et de la Recherche Médicale, France | N/A |
| Withdrawn | Avatrombopag for Thrombocytopenia in People With Cancer NCT04437953 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors NCT04609891 | Anhui Provincial Cancer Hospital | N/A |
| Completed | Bioequivalence Test of Eltrombopag Olamine Tablets in Humans Under Fasting State NCT06768632 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | N/A |
| Unknown | HIV Indicator Diseases in Hospital and Primary Care NCT05225493 | Erasmus Medical Center | — |
| Completed | Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopen NCT04014166 | Institute of Hematology & Blood Diseases Hospital, China | N/A |
| Completed | Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2 NCT05585463 | Fundació Sant Joan de Déu | — |
| Completed | Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia NCT03638817 | University Hospital, Toulouse | Phase 2 |
| Completed | Post-Operative Thrombocytopenia After Bio-prosthesis Implantation NCT03835598 | Maastricht University Medical Center | — |
| Terminated | The SOLID Platelet Study NCT03712618 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Completed | Effects of a Platelet Transfusion Best Practices Alert NCT04155775 | Stanford University | N/A |
| Completed | A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-ineffici NCT03754634 | Shandong University | Phase 2 |
| Terminated | A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia NCT03806556 | Meghan McCormick | Phase 1 / Phase 2 |
| Recruiting | The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia NCT02707497 | Ruilan Wang | Phase 2 / Phase 3 |
| Completed | XIENCE 28 USA Study NCT03815175 | Abbott Medical Devices | N/A |
| Recruiting | Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients NCT03998059 | Institute of Hematology & Blood Diseases Hospital, China | — |
| Completed | Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients NCT06565364 | Medical University of Vienna | — |
| Completed | Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia NCT04348799 | yangjie | — |
| Enrolling By Invitation | Function of Platelets Used for Transfusions NCT05038722 | Sofia Ramström | — |
| Unknown | Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women NCT03767803 | Progenity, Inc. | — |
| Unknown | High-dose Use of rhTPO in CIT Patients NCT03633019 | First Affiliated Hospital Xi'an Jiaotong University | Phase 4 |
| Unknown | TTP and aHUS in Complicated Pregnancies NCT03605511 | University College, London | — |
| Unknown | Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML NCT03701217 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | Mortality Due to Septic Shock Associated With Thrombocytopenia NCT03617965 | Universidad de Guanajuato | — |
| Terminated | Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure NCT03554759 | Sobi, Inc. | — |
| Completed | Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT NCT03515096 | Shenzhen Second People's Hospital | Phase 3 |
| Terminated | Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis NCT03303950 | University of Utah | Phase 2 |
| Terminated | Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure NCT03326843 | Sobi, Inc. | Phase 3 |
| Unknown | Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia NCT03288441 | Maastricht University Medical Center | — |
| Completed | Thrombosomes® in Bleeding Thrombocytopenic Patients NCT03394755 | Cellphire Therapeutics, Inc. | Phase 1 |
| Terminated | Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy NCT03391856 | Peking University People's Hospital | Phase 2 / Phase 3 |
| Completed | XIENCE 28 Global Study NCT03355742 | Abbott Medical Devices | N/A |
| Completed | Thrombocytopenia Drug Immune Validation of New Biological Test Diagnostic NCT02862353 | Centre Hospitalier Universitaire de Saint Etienne | — |
| Unknown | Study of Sirolimus in CTD-TP in China NCT03688191 | Peking Union Medical College Hospital | Phase 4 |
| Completed | Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chr NCT02948283 | City of Hope Medical Center | Phase 1 |
| Completed | Thrombocytopenia Induced by Chemotherapy NCT03567798 | Socrates School Of Health | N/A |
| Terminated | Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia NCT03195010 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Platelet Reactivity in Septic Shock NCT03716310 | Università degli Studi di Ferrara | — |
| Terminated | Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia NCT03059030 | Northwestern University | N/A |
| Withdrawn | The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis NCT03090919 | Susan Smyth | N/A |
| Completed | Efficacy of Sialic Acid GNE Related Thrombocytopenia NCT02845609 | Hadassah Medical Organization | Phase 2 |
| Completed | Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transf NCT02858323 | National Institutes of Health Clinical Center (CC) | — |
| Completed | American Trial Using Tranexamic Acid in Thrombocytopenia NCT02578901 | University of Washington | Phase 3 |
| Withdrawn | Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelof NCT02805868 | Northwestern University | EARLY_Phase 1 |
| Completed | Effect of Chorioamnionitis on Platelet Activation and Placental Vessel Among Preterm Infants by Wnt-Flt1 Signa NCT03636698 | Guangdong Women and Children Hospital | — |
| Completed | Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopeni NCT02718716 | UCB Biopharma SRL | Phase 2 |
| Completed | A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management NCT01965626 | Shandong University | Phase 2 |
| Completed | Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers NCT02780414 | Progenity, Inc. | — |
| Completed | Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia NCT02530515 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Prospective Study of Patients With Thrombocytopenia Following HSCT NCT02487563 | The First Affiliated Hospital of Soochow University | Phase 3 |
| Completed | Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy NCT02679443 | Post Graduate Institute of Medical Education and Research, Chandigarh | N/A |
| Terminated | Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE NCT02444728 | Chinese SLE Treatment And Research Group | Phase 3 |
| Terminated | Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopen NCT02032134 | Napolitano Mariasanta | Phase 4 |
| Completed | Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergo NCT02389621 | Shionogi | Phase 3 |
| Completed | The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study NCT02371330 | Karolinska Institutet | — |
| Completed | Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe NCT02298933 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets NCT02078284 | U.S. Army Medical Research and Development Command | Phase 1 |
| Terminated | Observational Trial of a Therapeutic Platelet Transfusion Regimen NCT02276651 | Klinikum Nürnberg | — |
| Completed | Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients NCT02267993 | Institute of Hematology & Blood Diseases Hospital, China | Phase 4 |
| Unknown | Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia NCT02241031 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelo NCT02244658 | Shandong University | Phase 3 |
| Completed | A Study of Eltrombopag in Patients With CMML and Thrombocytopenia NCT02323178 | Groupe Francophone des Myelodysplasies | Phase 1 / Phase 2 |
| Terminated | Prevention of Thrombocytopenia in Glioblastoma Patients NCT02227576 | University Hospital, Lille | Phase 2 |
| Terminated | PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) NCT02074436 | Emory University | Phase 2 |
| Completed | Romiplostim in Thoracic Transplantation NCT03515447 | Nantes University Hospital | — |
| Unknown | rhTPO in Critical Patients With Thrombocytopenia NCT02094248 | Jinling Hospital, China | Phase 2 / Phase 3 |
| Completed | EMR Tool Impact on HIT Documentation and Management NCT05439265 | Rush University Medical Center | — |
| Completed | A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopa NCT02039076 | Eisai Inc. | Phase 1 |
| Unknown | French Adult Primary Immune Thrombocytopenia NCT03429660 | University Hospital, Toulouse | — |
| Completed | Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. NCT01791101 | Gruppo Italiano Malattie EMatologiche dell'Adulto | Phase 2 |
| Terminated | Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C NCT01821625 | University of Texas Southwestern Medical Center | Phase 2 / Phase 3 |
| Completed | Bleeding Prediction in Thrombocytopenia NCT02306044 | Pernille Just Vinholt | — |
| Terminated | Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy NCT01676961 | NYU Langone Health | Phase 2 |
| Completed | Evaluate the Association Between Infection and Thrombocytopenia NCT02263157 | Jinling Hospital, China | — |
| Terminated | Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia NCT01727401 | G. d'Annunzio University | Phase 4 |
| Withdrawn | Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant NCT01660347 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | N/A |
| Terminated | Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma NCT01484314 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Re NCT01428635 | M.D. Anderson Cancer Center | Phase 2 / Phase 3 |
| Completed | Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients NCT01444417 | Amgen | Phase 3 |
| Completed | Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501 NCT01355289 | Eisai Inc. | Phase 2 |
| Completed | Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) NCT01481220 | Nordic MDS Group | Phase 1 |
| Terminated | Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG) NCT01397149 | University of Ulm | Phase 1 / Phase 2 |
| Active Not Recruiting | Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes NCT02912208 | Associazione Qol-one | Phase 2 |
| Terminated | Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia NCT01286038 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |
| Completed | A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodyspl NCT00961064 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Unknown | Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP NCT01805648 | Peking Union Medical College | Phase 3 |
| Unknown | The International ITP Registry NCT01970189 | South Eastern Sydney Local Health District | — |
| Completed | Pathogen Reduction Evaluation & Predictive Analytical Rating Score NCT02783313 | Sanquin Research & Blood Bank Divisions | N/A |
| Completed | Effect of Hemodialysis Membranes on Platelet Count NCT01356576 | Northwell Health | — |
| Terminated | Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study) NCT01368211 | Terumo BCTbio | Phase 2 / Phase 3 |
| Unknown | Immune Thrombocytopenia (ITP) Immune-Genetic Assessment NCT01196884 | Azienda Sanitaria-Universitaria Integrata di Udine | — |
| Withdrawn | Study of Eltrombopag in Platelet Refractory Thrombocytopenia NCT01194167 | University of Cincinnati | Phase 2 |
| Completed | Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome NCT01165996 | Case Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Terminated | Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia NCT01153919 | University of Southern California | Phase 2 |
| Completed | Eltrombopag for Post Transplant Thrombocytopenia NCT01000051 | M.D. Anderson Cancer Center | Phase 2 |
| Unknown | Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory NCT01162941 | Cooperative Study Group A for Hematology | Phase 2 |
| Completed | Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or S NCT01002755 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia NCT01974401 | Mashhad University of Medical Sciences | Phase 2 |
| Completed | Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation NCT00903929 | Jane Liesveld | Phase 1 |
| Completed | Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated W NCT00907478 | Amgen | Phase 4 |
| Terminated | Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients NCT00909363 | Weill Medical College of Cornell University | Phase 2 |
| Completed | A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients NCT00922883 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Study of the Effect of Differing Platelet Transfusion Times in Neonates NCT00948792 | University of Oklahoma | N/A |
| Unknown | The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC NCT02344979 | Shenyang Sunshine Pharmaceutical Co., LTD. | — |
| Completed | Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal NCT00771810 | Tarix Pharmaceuticals | Phase 2 |
| Completed | Transfusing Neonates Based on Platelet Mass NCT00759980 | Christiana Care Health Services | — |
| Completed | Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemi NCT00735930 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells NCT00730314 | Children's Hospital Los Angeles | Phase 1 / Phase 2 |
| Completed | Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome NCT00614523 | Amgen | Phase 2 |
| Terminated | Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocyto NCT00678587 | GlaxoSmithKline | Phase 3 |
| Completed | Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation) NCT00748878 | University of Utah | — |
| Terminated | Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study) NCT00594685 | Carelon Research | — |
| Completed | Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With NCT00472290 | Amgen | N/A |
| Completed | Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell NCT00413283 | Amgen | Phase 2 |
| Completed | A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving R NCT00418665 | Amgen | Phase 2 |
| Completed | Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura NCT00415532 | Amgen | Phase 3 |
| Terminated | Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Thera NCT00471653 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Completed | Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (M NCT00321711 | Amgen | Phase 2 |
| Completed | Mechanism of Thrombocytopenia in Infants NCT00333333 | Christiana Care Health Services | — |
| Completed | Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura NCT00454857 | Amgen | — |
| Completed | Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) NCT00303472 | Amgen | Phase 2 |
| Completed | Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products NCT00263809 | Terumo BCTbio | EARLY_Phase 1 |
| Completed | Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia NCT00260689 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With NCT00283439 | Amgen | Phase 1 / Phase 2 |
| Completed | Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days NCT00261924 | Cerus Corporation | Phase 3 |
| Completed | Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in NCT00118664 | Children's Healthcare of Atlanta | — |
| Completed | AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior t NCT00102336 | Amgen | Phase 3 |
| Completed | SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatiti NCT00110799 | GlaxoSmithKline | Phase 2 |
| Completed | AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refract NCT00102323 | Amgen | Phase 3 |
| Terminated | Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infectio NCT00239733 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 |
| Completed | An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP NCT00508820 | Amgen | Phase 3 |
| Unknown | Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B Cirrhosis NCT01987791 | Peking University People's Hospital | — |
| Completed | Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thro NCT00116688 | Amgen | Phase 3 |
| Completed | Optimal Platelet Dose Strategy for Management of Thrombocytopenia NCT00128713 | Carelon Research | Phase 3 |
| Completed | Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy NCT01163110 | Midwestern Regional Medical Center | Phase 1 |
| Terminated | Strategies for Transfusion of Platelets (SToP) NCT00420914 | Hamilton Health Sciences Corporation | Phase 3 |
| Completed | Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE NCT00073580 | The Medicines Company | Phase 3 |
| Completed | Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma NCT00151866 | Sanquin Research & Blood Bank Divisions | Phase 3 |
| Completed | Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin NCT00039858 | Encysive Pharmaceuticals | Phase 4 |
| Completed | Thrombopoietin Levels and Platelet Transfusion in Neonates NCT00549484 | Christiana Care Health Services | — |
| Terminated | Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen NCT00074165 | OHSU Knight Cancer Institute | Phase 2 |
| Completed | Daclizumab to Treat Chronic Immune Thrombocytopenia NCT00049725 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Completed | Platelet Count Trends in Pre-eclamptic Parturients NCT00787241 | Northwestern University | — |
| Completed | Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer NCT00031980 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Terminated | Aspirin in Patients With Myocardial Infarction and Thrombocytopenia NCT00501345 | M.D. Anderson Cancer Center | Phase 3 |
| Completed | Blood Products in Cardiac Surgery NCT02068755 | University of Turku | — |
| Completed | Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment NCT00608738 | Northwestern University | N/A |
| Completed | Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus NCT00015639 | National Institutes of Health Clinical Center (CC) | — |
| Completed | Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer NCT00012376 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young P NCT00305708 | University of California, San Francisco | Phase 1 / Phase 2 |
| Completed | Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia NCT00039910 | Pfizer | Phase 3 |
| Completed | Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia NCT00037791 | Pfizer | Phase 3 |
| Completed | Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia NCT00004215 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients NCT00003619 | Drexel University College of Medicine | Phase 1 / Phase 2 |
| Completed | Treatment of Autoimmune Thrombocytopenia (AITP) NCT00001630 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
| Completed | Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine NCT00001533 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
| Completed | SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previ NCT00002665 | SWOG Cancer Research Network | Phase 2 |
| Completed | Stem Cell Transplantation (SCT) for Genetic Diseases NCT00004378 | National Center for Research Resources (NCRR) | N/A |
| Completed | Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes NCT00004787 | National Center for Research Resources (NCRR) | Phase 2 |
| Available | Managed Access Programs for ETB115, Eltrombopag NCT04837703 | Novartis Pharmaceuticals | — |